A phase II study of palliative treatment with metallic stents for inoperable malignant colorectal strictures. (JIVROSG-0206) - Colorectal stent (JIVROSG-0206)

Japan Interventional Radiology in Oncology Study Group (JIVROSG)0 个研究点目标入组 33 人开始时间: 2005年8月6日最近更新: 2023年10月17日

适应症

试验速览

阶段: 2 期
状态: 已完成
发起方
入组人数: 33

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

Technical success: 97.0% (32/33) Clinical success (SE+ME, ≥2w): 81.8% (27/33) Mortality within 30 days: 3 (progression of the primary disease) Clinical failure due to the obstruction of other sites: 1 Stent removal from anal pain: 1 Adverse events (grade 2-3): diarrhea 12, pain 5, bleeding 1, dysuria 1

研究设计

研究类型: Interventional

入排标准

年龄范围: ot applicable 至 ot applicable（—）
性别: All

入选标准

未提供

排除标准

•1) The operation for colostomy scheduled. 2) Stenting as the preoperative preparation for the resection. 3) Serious bleeding from the lesion. 4) Pregnancy.

研究者

发起方

Japan Interventional Radiology in Oncology Study Group (JIVROSG)

相似试验

已完成

不适用

A phase II study about the efficacy of an intervention of excercise therapy on the adjuvant chemotherapy for pancreatic cancer: Exercise-PC Study

JPRN-UMIN000030124Wakayama Medical University43

已完成

2 期

Phase 2 study evaluating the efficacy and safety of the combination of Bendamustine, Rituximab and Dexamethazone (RBenda-D) for treatment of CD20-positive relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.Relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.

JPRN-UMIN000008145Kyoto Prefectural University of Medicine/K-LSG33

进行中（未招募）

2 期

A clinical trial of neoadjuvant taxane chemotherapy for women with locally advanced breast cancerocally advanced breast cancerLocally advanced breast cancerCancer - Breast

ACTRN12606000305527The Cancer Council Victoria40

已完成

2 期

Efficacy and Safety Study of Sorafenib Plus Pravastatin to Treat Advanced HepatocarcinomaAdvanced Hepatocarcinoma

NCT01418729Hospital Donostia216

已完成

2 期

Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver MetsPancreatic CancerLiver Cancer

NCT01581307H. Lee Moffitt Cancer Center and Research Institute9